# Vision Medicals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vision-medicals

- Industry: Healthcare
- Headquarters: Guangzhou, China
- Website: www.visionmedicals.com
- Total disclosed funding: $121M
- Latest round: Series D (May 16, 2024)
- Investors on record: 8

## About

Based in Guangzhou, China and established in 2018, Vision Medicals operates as a gene diagnosis services provider which focuses on providing technologies of CRISPR (Clustered regularly interspaced short palindromic repeats) and NGS (Next-generation" sequencing). It cooperates with hospitals to provide gene editing and gene sequencing technologies through big data and artificial intelligence. The company have 10 authorized patents and nearly 20 software works, besides, the company also has built over 10,000 square meters of R&D center, medical testing laboratory and in vitro diagnostic reagent GMP production base, and has medical testing laboratories and branches in Beijing, Shanghai, Nanjing, Zhengzhou and Chengdu.

The company self developed products include pathogen metagenomics platform IDseq and pathogen CRISPR rapid diagnosis platform ID-CRISPR. The company provides infectious pathogen genetic diagnosis service for customers. The company is main business is clinical laboratory services, medical research and experimental development, biotechnology development services, biomedical technology research, biotechnology promotion services, biotechnology consulting and biotechnology transfer services

The company plans to use the series D funding for product development and upgrading, medical device product registration, industrial chain layout.

## Funding rounds

- Series D, May 16, 2024 — Hundreds Capital, Kequan Fund
- Series D, Nov 25, 2021, $47M — CDH Investments, Tencent Investment, Boyu Capital
- Series C, Feb 4, 2021, $31M — CDH Investments, China International Capital Corporation, Tencent Investment, CASH Capital
- Series B, Aug 12, 2020, $29M — CDH Investments, China International Capital Corporation, CASH Capital, Volcanics Venture
- Series A, Sep 11, 2019, $14M — CASH Capital, Volcanics Venture

## Investors

- CASH Capital (https://capitalatlas.ai/funds/cash-capital) — Series A, Series B, Series C
- Volcanics Venture (https://capitalatlas.ai/funds/volcanics-venture) — Series A, Series B
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series B, Series C, Series D
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B, Series C
- Tencent Investment — Series C, Series D
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series D
- Hundreds Capital (https://capitalatlas.ai/funds/hundreds-capital) — Series D
- Kequan Fund — Series D